PRNewsWire - Health

Avidity Biosciences Announces the Accelerated Approval Regulatory Pathway in the U.S. is Open for Del-Brax and Initiates the Global, Confirmatory Phase 3 FORWARD™ Study in FSHD
Veritas Veterinary Partners Advances Strategic Growth Plan with Key Investments and Executive Appointments
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
WuXi Biologics Kicks off Construction of Microbial Manufacturing Site for Commercial Production in Chengdu